Tanimoto Sarina sold SPRY

February 28, 2024 · Form 4 insider transaction

Tanimoto Sarina sold 49,019 shares of ARS Pharmaceuticals, Inc. at $9.02 per share, a transaction worth $442.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
49,019
Price
$9.02
Total value
$442.2K
RoleOfficer, 10% owner
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 28, 2024
Filing dateFebruary 28, 2024
Shares owned after2,050,481
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.; The weighted average sale price for the transaction reported was $9.0212, and the range of prices were between $9.00 and $9.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.; The shares are held in trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of the trust.

View the original Form 4 on SEC EDGAR